News Digest December 2022
A curation of news stories impacting health insurance and brokers, population health management and health tech from last month.
Welcome to 2023, albeit we say it with caution, as the many annual soothsayers’ predictions – a selection of which we kick off with – are universally gloomy: beware horribly rising healthcare costs, potential recessions, a quiet capital/IPO market etc, etc.
However, the mighty dollar, some sanity on digital asset prices, high health insurer share prices, alongside continued predicted PMI/IPMI growth should bring some balance: see the 2022 performance of UnitedHealthcare, Cigna and Metlife.
And so, in turn, we might predict more global M&A in our space, as faster digitalisation/tech, scale, portfolio balance re-assert their importance for health insurers.
In most other areas there is very little of note to report, which I suppose is not that surprising for the very busy renewal month of December.